IMO the best hope here is a take over by GE Health.Double digit...

IMO the best hope here is a take over by GE Health.

Double digit sales increase via GE, with costs 100x revenue this quarter, double digit sales growth will take a long time to over take costs. GE has so much in place that would stop doubling up on costs, sales teams in US etc that it seems an obvious fit for them.

A$2.9 Mil costs for a quarter (after 60% reduction !!) = approx A$12 Mil per year for a A$32 Mil MC company


Approx A$12 Mil in cash so at approx A$3 Mil a quarter = 1 year of funds left. If GE is going to make a move, it would be approx mid 2021, when they have assessed sales, fit of product with their offerings & OSP $$ in bank fading.
.